Supriya Lifescience Share Price
859.65+16.95 (+2.01%)
+29.79% past 1 Year
Supriya Lifescience Limited is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients (APIs), with a focus on research and development. The company has niche product offerings
Corporate filings & documents
Announcements
Enclosed herewith is the copy of Letter dispatched to shareholders whose email ids are not registered.Kindly take the same on record.
1 day agoEnclosed herewith is the copy of Letter dispatched to shareholders whose email ids are not registered.Kindly take the same on record.
1 day agoEnclosed herewith disclosure under Regulation 30.
1 day agoEnclosed herewith disclosure under Regulation 30.
1 day agoCopy of Newspaper Public for dispatch of AGM Notice and Annual Report.
1 day agoCopy of Newspaper Public for dispatch of AGM Notice and Annual Report.
1 day agoBusiness Responsibility and Sustainability Report for FY 2025-26
2 days agoBusiness Responsibility and Sustainability Report for FY 2025-26
2 days agoNotice of 18th AGM of the Company.
2 days agoNotice of 18th AGM of the Company.
2 days agoAnnual Report
2 days agoAnnual Report
2 days agoCopy of Newspaper Publication is enclosed.
1 week agoCopy of Newspaper Publication is enclosed.
1 week agoEnclosed herewith is the intimation of record date for determining list of members eligible to receive dividend for FY 2025-26.
1 week agoEnclosed herewith is the intimation of record date for determining list of members eligible to receive dividend for FY 2025-26.
1 week agoScrutinizers Report and Voting Results for Postal ballot conducted by the Company are enclosed herewith.
1 week agoScrutinizers Report and Voting Results for Postal ballot conducted by the Company are enclosed herewith.
1 week agoVoting Results and Scrutinizers Report for the Postal ballot conducted by the Company are enclosed herewith.
1 week agoVoting Results and Scrutinizers Report for the Postal ballot conducted by the Company are enclosed herewith.
1 week agoEarnings Call Transcript of the Earning Call for Unaudited Financial Results for quarter ended June 30 2026 is enclosed.
2 weeks agoEarnings Call Transcript of the Earning Call for Unaudited Financial Results for quarter ended June 30 2026 is enclosed.
2 weeks agoAudio Link for outcome of Results Earnings Call for United Financial Results for quarter ended June 30 2026 is enclosed.
2 weeks agoAudio Link for outcome of Results Earnings Call for United Financial Results for quarter ended June 30 2026 is enclosed.
2 weeks agoEnclosed herewith Copy of Newspaper Publication of Results for quarter ended June 30 2026.
2 weeks agoEnclosed herewith Copy of Newspaper Publication of Results for quarter ended June 30 2026.
2 weeks agoPress Release for Unaudited Financial Results for quarter ended June 30 2026 is enclosed herewith.
3 weeks agoInvestor Presentation for Results Earnings Call for Unaudited Financial Results for quarter ended June 30 2026 is enclosed herewith.
3 weeks agoInvestor Presentation for Results Earnings Call for Unaudited Financial Results for quarter ended June 30 2026 is enclosed herewith.
3 weeks agoUnaudited Financial Results for the quarter ended June 30 2026 is enclosed.
3 weeks agoUnaudited Financial Results for the quarter ended June 30 2026 is enclosed.
3 weeks agoPursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the Board of Directors of the Company at its Meeting held on Thursday August 13 2026 inter-alia considered and approved Unaudited Financial Results for the Quarter ended June 30 2026. A copy of the same is enclosed along with the Limited Review Report of the Statutory Auditors thereon in terms of SEBI (LODR) Regulations 2015. The Meeting of the Board of Directors of the Company commenced at 03:30 p.m. and concluded at 06.00 p.m.Kindly take the above information on your records.
3 weeks agoPursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the Board of Directors of the Company at its Meeting held on Thursday August 13 2026 inter-alia considered and approved Unaudited Financial Results for the Quarter ended June 30 2026. A copy of the same is enclosed along with the Limited Review Report of the Statutory Auditors thereon in terms of SEBI (LODR) Regulations 2015. The Meeting of the Board of Directors of the Company commenced at 03:30 p.m. and concluded at 06.00 p.m.Kindly take the above information on your records.
3 weeks agoIntimation of the Earnings call for Unaudited Financial Results of the Company for the quarter ended June 30 2026 is enclosed herewith.
3 weeks agoIntimation of the Earnings call for Unaudited Financial Results of the Company for the quarter ended June 30 2026 is enclosed herewith.
3 weeks agoSupriya Lifescience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve In terms of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this to inform you that a meeting of the Board of Directors of the Company will be held on Thursday August 13 2026 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30 2026.This is to further inform you that in accordance with the Companys Code of Conduct for Prevention of Insider Trading the Trading Window for dealing in the securities of the Company by Designated Persons and their immediate relatives is closed from July 1 2026 till 48 hours after declaration of Unaudited Financial Results on August 13 2026.
4 weeks agoSupriya Lifescience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve In terms of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this to inform you that a meeting of the Board of Directors of the Company will be held on Thursday August 13 2026 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30 2026.This is to further inform you that in accordance with the Companys Code of Conduct for Prevention of Insider Trading the Trading Window for dealing in the securities of the Company by Designated Persons and their immediate relatives is closed from July 1 2026 till 48 hours after declaration of Unaudited Financial Results on August 13 2026.
4 weeks agoPlease find attached copy of Newspaper Publication of Postal Ballot Notice.
1 month agoPlease find attached copy of Newspaper Publication of Postal Ballot Notice.
1 month agoPlease Find Attached Postal Ballot Notice of Supriya Lifescience Limited.
1 month agoPlease Find Attached Postal Ballot Notice of Supriya Lifescience Limited.
1 month agoEnclosed herewith is the Certificate under Regulation 74 (5) of SEBI (DP) Regulations 2018 received from RTA.
1 month agoEnclosed herewith is the Certificate under Regulation 74 (5) of SEBI (DP) Regulations 2018 received from RTA.
1 month agoEnclosed herewith is the intimation for submission under Regulation 30 of SEBI (LODR) Regulations 2015.
2 months agoEmail Communication to Shareholders regarding Dividend Taxation Provisions.
2 months agoEmail Communication to Shareholders regarding Dividend Taxation Provisions.
2 months agoEnclosed herewith is the intimation for trading window closure for declaration of Unaudited Financial Results for quarter ending on June 30 2026.
2 months agoEnclosed herewith is the intimation for trading window closure for declaration of Unaudited Financial Results for quarter ending on June 30 2026.
2 months agoIntimation of Analyst / Investor Meeting is enclosed herewith.
2 months agoIntimation of Analyst / Investor Meeting is enclosed herewith.
2 months agoAnnual reports
Concalls & investor presentations
Aug 2026
ConcallPresentation
Aug 2026
ConcallPresentation
May 2026
ConcallPresentation
May 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Aug 2025
ConcallPresentation
Aug 2025
ConcallPresentation
May 2025
ConcallPresentation
Jan 2025
ConcallPresentation
Jan 2025
ConcallPresentation
Oct 2024
Aug 2024
ConcallPresentation
Aug 2024
ConcallPresentation
May 2024
ConcallPresentation
May 2024
ConcallPresentation
Feb 2024
ConcallPresentation
Feb 2024
ConcallPresentation
Nov 2023
ConcallPresentation
Nov 2023
ConcallPresentation
Aug 2023
ConcallPresentation
Aug 2023
ConcallPresentation
May 2023
ConcallPresentation
May 2023
ConcallPresentation
Feb 2023
ConcallPresentation
Feb 2023
ConcallPresentation
Nov 2022
ConcallPresentation
Nov 2022
ConcallPresentation
Aug 2022
ConcallPresentation
Aug 2022
ConcallPresentation
May 2022
ConcallPresentation
May 2022
ConcallPresentation
Jan 2022
Corporate Actions
Date
Type
Details
2026-09-04
Dividend
1.0
2025-09-04
Dividend
1.0
2024-09-20
Dividend
0.8
2023-09-15
Dividend
0.6
2022-09-01
Dividend
0.6
Company details
Registered office
207/208, Udyog Bhavan Sonawala Road Goregaon (East) Mumbai Maharashtra PIN: 400063 Tel No: 022-40332727 Fax No: 022-26860011 Email: [email protected] Internet: www.supriyalifescience.com
Registrars
C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra C 101, 247 Park LBS Marg Vikhroli (West) PIN: Tel No: +91 810 811 8484 Fax No: 91-022-49186060 Email: [email protected] Internet: https://in.mpms.mufg.com/
Management
Prachi Sathe, Company Secretary & Compliance Officer
Satish Waman Wagh, Chairman
Saloni Satish Wagh, Managing Director
Shivani Satish Wagh, Joint Managing Director
Smita Satish Wagh, Whole Time Director
Balasaheb Gulabrao Sawant, Whole Time Director
Neelam Yashpal Arora, Non Executive Independent Director
Ganapati Dadasaheb Yadav, Non Executive Independent Director
Sunil Subhash Bhagwat, Non Executive Independent Director
Kothandaraman Hari, Non Executive Independent Director
Manish Panchal, Non Executive Independent Director
Details
BSE 543434
NSE SUPRIYA
ISIN INE07RO01027